Litcius/Paper detail

Capsular genotype distribution of Group B Streptococcus colonization among at-risk pregnant women in Sao Paulo, Brazil.

Renato de Ávila Kfouri, Antônio Carlos Campos Pignatari, Elisa Junko Ura Kusano, Talita Trevizani Rocchetti, Clara Lopes Fonseca, Lily Yin Weckx

2021The Brazilian Journal of Infectious Diseases19 citationsDOIOpen Access PDF

Abstract

BACKGROUND: Vaccines in development against Group B Streptococcus (GBS) should contain the most prevalent capsular genotypes screened in the target population. In low- and middle-income countries epidemiological data on GBS carriage among pregnant women, a prerequisite condition for GBS neonatal sepsis, is needed to inform vaccine strategies. OBJECTIVE: To investigate the prevalence of different GBS capsular genotypes that colonizes at-risk pregnant women in a private maternity hospital in São Paulo, Brazil. METHODS: GBS strains isolated in routine maternity procedures from at-risk pregnant women from 2014 to 2018 were confirmed by mass spectrometry (MALDI-TOF) with subsequent DNA extraction for identification of capsular genotype through polymerase chain reaction (PCR). Demographic and gestational data were analyzed. RESULTS: A total of 820 Todd-Hewitt broths positive for GBS were selected for streptococcal growth. Recovery and confirmation of GBS by MALDI-TOF were possible in 352. Strains were processed for determination of capsular genotype by PCR. From the total of 352 GBS isolates, 125 strains (35.5%) were genotyped as Ia; 23 (6.5%) as Ib; 41 (11.6%) as II; 36 (10.2%) as III; 4 (1.1%) as IV; 120 (34.1%) as V and 1 strain (0.3%) as VIII. Two isolates (0.7%) were not genotyped by used methodology. No statistically significant correlation between gestational risk factors, demographic data and distribution of capsular genotypes were found. CONCLUSIONS: GBS capsular genotypes Ia, Ib, II, III, and V were the most prevalent isolates colonizing at risk pregnant women in the present study. The inclusion of capsular genotypes Ia and V in the composition of future vaccines would cover 69.6% of capsular genotypes in the studied population. No statistically significant differences were observed between capsular genotype and gestational and demographic data and risk factors.

Topics & Concepts

GenotypeGroup BCarriageStreptococcusPopulationNeonatal sepsisPolymerase chain reactionEpidemiologyMedicineBiologyObstetricsMicrobiologySepsisInternal medicineBacteriaGeneticsEnvironmental healthGenePathologyNeonatal and Maternal InfectionsPreterm Birth and ChorioamnionitisCOVID-19 Impact on Reproduction